<DOC>
	<DOCNO>NCT01750255</DOCNO>
	<brief_summary>This project aim , pharmaceutical care patient Bipolar I Disorder , improve compliance adherence rate , associate great effectiveness safety drug therapy help achieve therapeutic goal , finally improve quality life patient .</brief_summary>
	<brief_title>Effect Pharmaceutical Care Patients With Bipolar I Disorder ( BD I )</brief_title>
	<detailed_description>The objective present study ass effectiveness Dader Method pharmaceutical care reduction use health care service increase effectiveness safety treatment patient Bipolar I Disorder discharge referred outpatient clinic St John God-La Ceja . Primary objective : To assess effectiveness Dader method pharmaceutical care achieve reduce number hospital readmission , increase effectiveness safety treatment patient discharge Clinic Saint John God -La Ceja - Antioquia bipolar disorder . A randomized controlled trial . 200 patient randomize group control intervention . Post-randomisation , patient require attend clinic routinely every 3 month one year . Every 3 month evaluate criterion effectiveness safety treatment . Intervention 's group follow pharmaceutical care . In development study record use health care service ( rehospitalizations , care emergency outpatient , additional schedule ) .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Patients diagnose Bipolar I Disorder Have discharge Clinic Saint John God La Ceja Have result external consultation ( outpatient ) Clinic Saint John God La Ceja Male female patient age 18 65 year Living Medellin follow eastern municipality department Antioquia . Patients first episode manic type , schizoaffective disorder , bipolar disorder II , cyclothymia bipolar spectrum disorder , personality disorder seem bipolar disorder , sociopathic disorder . Epilepsy Patients unable comply protocol requirement , include severe alcohol drug use . Patients diagnostic uncertainty . Pregnancy breastfeed Infection human immunodeficiency virus ( HIV ) . Chronic decompensate disease ( significant disease ) : blood pressure value 180/110 mmHg , total cholesterol 300 mg / dL , low density cholesterol great 160 mmHg , hemoglobin A1c great 9 % , low oxygen saturation 90 % . Mental retardation , presence cognitive impairment prevents understand sign informed consent . Refusal sign inform consent ( Consent must obtain studyrelated procedure conduct ) . Illiteracy . Patients electroconvulsive therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Pharmaceutical care</keyword>
	<keyword>Pharmacotherapy follow-up</keyword>
	<keyword>Bipolar disorder</keyword>
	<keyword>Pharmacy service</keyword>
</DOC>